
Phase 3 NEJM data show oveporexton improves wakefulness, reduces cataplexy, and boosts quality of life in narcolepsy type 1, with manageable adverse effects.
Refreshed sleep can be tough even during normal times. With up to 30% of Americans experiencing sleep problems, here are guidelines to a better night’s sleep.